» Articles » PMID: 11432824

Lysine 188 Substitutions Convert the Pattern of Proteasome Activation by REGgamma to That of REGs Alpha and Beta

Overview
Journal EMBO J
Date 2001 Jul 4
PMID 11432824
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

11S REGs (PA28s) are multimeric rings that bind proteasomes and stimulate peptide hydrolysis. Whereas REGalpha activates proteasomal hydrolysis of peptides with hydrophobic, acidic or basic residues in the P1 position, REGgamma only activates cleavage after basic residues. We have isolated REGgamma mutants capable of activating the hydrolysis of fluorogenic peptides diagnostic for all three active proteasome beta subunits. The most robust REGgamma specificity mutants involve substitution of Glu or Asp for Lys188. REGgamma(K188E/D) variants are virtually identical to REGalpha in proteasome activation but assemble into less stable heptamers/hexamers. Based on the REGalpha crystal structure, Lys188 of REGgamma faces the aqueous channel through the heptamer, raising the possibility that REG channels function as substrate-selective gates. However, covalent modification of proteasome chymotrypsin-like subunits by 125I-YL3-VS demonstrates that REGgamma(K188E)'s activation of all three proteasome active sites is not due to relaxed gating. We propose that decreased stability of REGgamma(K188E) heptamers allows them to change conformation upon proteasome binding, thus relieving inhibition of the CT and PGPH sites normally imposed by the wild-type REGgamma molecule.

Citing Articles

Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution.

Persico M, Santoro A, DUrso A, Milardi D, Purrello R, Cunsolo A Biomolecules. 2022; 12(6).

PMID: 35740865 PMC: 9220251. DOI: 10.3390/biom12060741.


PA28γ: New Insights on an Ancient Proteasome Activator.

Cascio P Biomolecules. 2021; 11(2).

PMID: 33562807 PMC: 7915322. DOI: 10.3390/biom11020228.


CD8+ T Cell Co-Expressed Genes Correlate With Clinical Phenotype and Microenvironments of Urothelial Cancer.

Wang Y, Yan K, Lin J, Liu Y, Wang J, Li X Front Oncol. 2020; 10:553399.

PMID: 33330025 PMC: 7713665. DOI: 10.3389/fonc.2020.553399.


Proteasome interaction with ubiquitinated substrates: from mechanisms to therapies.

Chen X, Htet Z, Lopez-Alfonzo E, Martin A, Walters K FEBS J. 2020; 288(18):5231-5251.

PMID: 33211406 PMC: 8131406. DOI: 10.1111/febs.15638.


SIRT7 activates quiescent hair follicle stem cells to ensure hair growth in mice.

Li G, Tang X, Zhang S, Jin M, Wang M, Deng Z EMBO J. 2020; 39(18):e104365.

PMID: 32696520 PMC: 7507325. DOI: 10.15252/embj.2019104365.


References
1.
Knowlton J, Johnston S, Whitby F, Realini C, Zhang Z, Rechsteiner M . Structure of the proteasome activator REGalpha (PA28alpha). Nature. 1997; 390(6660):639-43. DOI: 10.1038/37670. View

2.
Udvardy A . Purification and characterization of a multiprotein component of the Drosophila 26 S (1500 kDa) proteolytic complex. J Biol Chem. 1993; 268(12):9055-62. View

3.
Ma C, Slaughter C, DeMartino G . Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem. 1992; 267(15):10515-23. View

4.
DeMartino G, Moomaw C, Zagnitko O, Proske R, Afendis S, Swaffield J . PA700, an ATP-dependent activator of the 20 S proteasome, is an ATPase containing multiple members of a nucleotide-binding protein family. J Biol Chem. 1994; 269(33):20878-84. View

5.
Baumeister W, Walz J, Zuhl F, Seemuller E . The proteasome: paradigm of a self-compartmentalizing protease. Cell. 1998; 92(3):367-80. DOI: 10.1016/s0092-8674(00)80929-0. View